RBC Says Galderma’s ZO Skin Health Deal Is a Smart Bolt-On
RBC Capital Markets analysts Harry Sephton and Mia Pachansky say the acquisition strengthens Galderma’s dermatological skincare portfolio and physician-dispensed channel.
Related stories
Murphy USA Publishes Q3 2026 Earnings Call Transcript
Murphy USA published a transcript of its third-quarter 2026 earnings call.
M impact | EQUITY | Oct 30, 2026, 03:15 AM UTC
Harbor Star Shipping Reports Quarterly Gross Revenue of 1.08 Billion Pesos
M impact | EQUITY | Oct 30, 2026, 03:15 AM UTC
Starbucks Publishes Q4 and Full-Year 2026 Earnings Call Transcript
M impact | EQUITY | Oct 30, 2026, 03:14 AM UTC
Lincoln Property Acquires 52,410-Square-Foot Medical Building Near San Antonio
M impact | EQUITY | Oct 30, 2026, 03:14 AM UTC
CIMC Group Reports Third-Quarter Revenue of RMB47.9 Billion
CIMC Group said third-quarter revenue rose 16.91% year over year and 3.57% quarter over quarter. The supplied body is truncated after introducing net profit.
M impact | EQUITY | Oct 30, 2026, 03:12 AM UTC
BOJ to Accelerate ETF Sales
The BOJ plans to accelerate the pace of sales of its ETF holdings.
M impact | EQUITY | Oct 30, 2026, 03:09 AM UTC